Now in pilot From the first hypothesis to the last regulatory filing  →

BioMate is a computational biology assistant for every stage of biomedical science.

BioMate AI works alongside your team across the whole arc of discovery — ranking targets, scoring molecules for ADMET and binding, simulating PK profiles, running genomics and cryo‑EM pipelines, and shaping clinical trial plans. Every result is quality‑graded and audit‑ready.

20+ biomedical domains Evidence-graded QC Your data stays yours
A scientist reviewing molecular data in the lab
Targets ranked
IL‑23A — #1 of 7 genetic support · drugability · safety
PK simulated
Predicted vs. observed 6 min · ready for DMPK review
Built for everyone doing hard biomedical science

Academic labs, pharma teams, CROs, core facilities — BioMate sits with the people doing the work.

A bench scientist working in a wet lab
In the labBench scientists, every day
A researcher reviewing data on multiple monitors
In the dataBioinformatics & discovery leads
A physician and a patient discussing care over a tablet
In the clinicTranslational & clinical teams
2,000+
validated workflows across 20+ biomedical domains
32
named QC profiles — each threshold cited to a published standard
<30 min
average time from question to QC-graded result
How it works

From question to result in three steps.

Describe what you need. BioMate selects the right workflow, runs it on cloud compute, and returns quality-checked, audit-ready results — in minutes, not days.

01

Ask in plain language.

Describe your scientific objective — a compound to profile, a dataset to process, a regulatory package to prepare. BioMate identifies the right validated workflow automatically.

02

Review and confirm.

See the workflow plan, check the parameters, adjust anything you need — then approve. BioMate runs the analysis on GPU-backed cloud compute. No code, no queue, no infrastructure to manage.

03

Get results that hold up.

Outputs arrive with evidence-graded QC, an AI-authored findings summary, a draft Methods section, and a complete audit trail. Ready for internal review, a regulatory submission, or the next experiment.

Coverage

From discovery to clinic.

Genomics, drug discovery, structural biology, clinical pharmacology, cryo-EM, multi-omics — these are the analyses where BioMate helps teams move from question to defensible result in hours, not weeks.

What we believe

Built for science, by people who care about getting it right.

A general‑purpose AI will happily make up a tool name or invent a parameter. In biomedical research, that means wrong results, wasted resources, and indefensible outputs. We made some choices — and we'd rather tell you about them than hide them.

Validated workflows, not guesses

Every workflow in BioMate maps to real published methodology. The AI routes to validated methods — it cannot invent a tool, a parameter, or a pipeline step.

QC with a citation

Gold, Silver, and Bronze thresholds are each cited to a primary source. You can always trace a QC decision back to the paper, guideline, or regulatory document that established it.

Reproducibility by design

Every run records tool versions, parameters, and QC decisions. Re-run any analysis identically at any time — the result resolves to the same methods and the same sources.

Your data, in your workspace

Analyses run in an isolated workspace. Your data is never used to train shared models, ever. HIPAA-ready, SSO-enabled, with role-based access on Team and Enterprise plans.

No code required

Describe your objective in plain language. BioMate selects the right workflow, pre-fills parameters, and runs the analysis. The scientific judgment stays with you.

Honest about what we do

BioMate automates computational workflows — not scientific reasoning. We tell you when a use case is outside the platform's scope, and we don't pretend otherwise.

See it in action

BioMate — The AI Lab Platform for Life Sciences

Spend a morning with BioMate.

Set up a workspace in under an hour. Bring the question that's been on your whiteboard for two weeks. See what comes back.